BI
BVF Inc Portfolio holdings
AUM
$2.8B
This Quarter Return
-26.78%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$765M
AUM Growth
+$765M
(-33%)
Cap. Flow
-$45.3M
Cap. Flow
% of AUM
-5.91%
Top 10 Holdings %
Top 10 Hldgs %
52.72%
Holding
58
New
1
Increased
22
Reduced
25
Closed
3
Top Buys
| 1 |
Arcus Biosciences
RCUS
|
$14.6M |
| 2 |
Kura Oncology
KURA
|
$10.7M |
| 3 |
Merus
MRUS
|
$8.4M |
| 4 |
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
|
$6.86M |
| 5 |
Verastem
VSTM
|
$5.13M |
Top Sells
| 1 |
Ionis Pharmaceuticals
IONS
|
$27.6M |
| 2 |
ARRY
Array Biopharma Inc
ARRY
|
$22M |
| 3 |
RGLS
Regulus Therapeutics
RGLS
|
$11.8M |
| 4 |
Xencor
XNCR
|
$8.83M |
| 5 |
KalVista Pharmaceuticals
KALV
|
$7.04M |
Sector Composition
| 1 | Healthcare | 83.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RGLS
51
DELISTED
Regulus Therapeutics
RGLS
| $979K | 0.13% |
1,051,940
-12,633,264
| -92% | -$11.8M |
|
|
VIRX
52
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $951K | 0.12% |
2,287,860
+603,224
| +36% | +$251K |
|
|
RLM
53
DELISTED
Realm Therapeutics plc American Depositary Shares
RLM
| $668K | 0.09% |
360,866
| – | – |
|
|
LOXO
54
DELISTED
Loxo Oncology, Inc
LOXO
| $552K | 0.07% |
3,944
-145
| -4% | -$20.3K |
|
|
55
Ionis Pharmaceuticals
IONS
$9.62B
| $508K | 0.07% |
9,399
-510,601
| -98% | -$27.6M |
|
|
KDNY
56
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| – | – |
-287,776
| Closed | -$2.12M |
|
|
TSRO
57
DELISTED
TESARO, Inc.
TSRO
| – | – |
-140,000
| Closed | -$5.46M |
|
58
Zymeworks
ZYME
$1.06B
| – | – |
-19,804
| Closed | -$311K |
|